ACTA1 and renal fibrosis: In Fig. 6, it showed that treatment with 3-MA could significantly decreased the expressions of renal fibrosis-related proteins (Vimentin, α-SMA, and TGF-β1) and autophagy-related proteins (ATG5 and LC3II).